PitchSend

Investor Presentaiton

NZ$ Million Australia grows despite lockdowns Australia total revenue Australia channel $80.0 1H $68.3 $70.0 $61.4 $60.0 $49.2 $50.3 $50.0 $40.0 29% 30% 1H 2021 59% 59% $30.0 $20.0 $10.0 11% 12% $28.5 $29.2 2% $0.0 FY2018 FY 2019 FY2020 FY2021 1H FY22 ■ OTC ■ Prescription ■ Hospital • Maxigesic and eyecare ranges lead growth and drive a positive half year outcome • OTC revenue growth hindered by COVID-19 particularly the Eastern states • Product launches delayed in the first half planned for the second half of the year • 30new product launches planned between now and the end of FY23 AFTpharmaceuticals 1H 2022 Page 6

View entire presentation